These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 23500072

  • 1. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine.
    Nagel A, Prado M, Heitmann A, Tartz S, Jacobs T, Deschermeier C, Helm S, Stanway R, Heussler V.
    Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072
    [Abstract] [Full Text] [Related]

  • 2. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
    Mueller AK, Labaied M, Kappe SH, Matuschewski K.
    Nature; 2005 Jan 13; 433(7022):164-7. PubMed ID: 15580261
    [Abstract] [Full Text] [Related]

  • 3. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS, Downie MJ, Mamoun CB, Kappe SH.
    Cell Microbiol; 2010 Jul 13; 12(7):930-8. PubMed ID: 20088947
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J, Matuschewski K.
    Vaccine; 2011 Sep 16; 29(40):7002-8. PubMed ID: 21787828
    [Abstract] [Full Text] [Related]

  • 5. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH.
    J Infect Dis; 2007 Aug 15; 196(4):608-16. PubMed ID: 17624848
    [Abstract] [Full Text] [Related]

  • 6. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, Franetich JF, Mazier D, Luty AJ, Sauerwein R, Janse CJ, Waters AP, Mota MM.
    Int J Parasitol; 2007 Nov 15; 37(13):1511-9. PubMed ID: 17604034
    [Abstract] [Full Text] [Related]

  • 7. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
    Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH.
    Vaccine; 2013 Oct 09; 31(43):4975-83. PubMed ID: 24029408
    [Abstract] [Full Text] [Related]

  • 8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.
    J Immunol; 2009 Nov 01; 183(9):5870-8. PubMed ID: 19812194
    [Abstract] [Full Text] [Related]

  • 9. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
    Annoura T, Ploemen IH, van Schaijk BC, Sajid M, Vos MW, van Gemert GJ, Chevalley-Maurel S, Franke-Fayard BM, Hermsen CC, Gego A, Franetich JF, Mazier D, Hoffman SL, Janse CJ, Sauerwein RW, Khan SM.
    Vaccine; 2012 Mar 30; 30(16):2662-70. PubMed ID: 22342550
    [Abstract] [Full Text] [Related]

  • 10. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
    Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW.
    Parasite Immunol; 2012 Dec 30; 34(12):562-9. PubMed ID: 23171040
    [Abstract] [Full Text] [Related]

  • 11. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
    Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, Schlüter D.
    Am J Pathol; 2007 Jul 30; 171(1):107-15. PubMed ID: 17591958
    [Abstract] [Full Text] [Related]

  • 12. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
    Jobe O, Lumsden J, Mueller AK, Williams J, Silva-Rivera H, Kappe SH, Schwenk RJ, Matuschewski K, Krzych U.
    J Infect Dis; 2007 Aug 15; 196(4):599-607. PubMed ID: 17624847
    [Abstract] [Full Text] [Related]

  • 13. Protective efficacy and safety of liver stage attenuated malaria parasites.
    Kumar H, Sattler JM, Singer M, Heiss K, Reinig M, Hammerschmidt-Kamper C, Heussler V, Mueller AK, Frischknecht F.
    Sci Rep; 2016 May 31; 6():26824. PubMed ID: 27241521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites.
    van der Velden M, Rijpma SR, Verweij V, van Gemert GJ, Chevalley-Maurel S, van de Vegte-Bolmer M, Franke-Fayard BM, Russel FG, Janse CJ, Sauerwein RW, Koenderink JB.
    Am J Trop Med Hyg; 2016 Aug 03; 95(2):378-82. PubMed ID: 27296385
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M, Tang J, Miyakoda M, Kaneko O, Yui K, Culleton R.
    Int J Parasitol; 2012 Aug 03; 42(9):859-70. PubMed ID: 22846785
    [Abstract] [Full Text] [Related]

  • 18. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.
    Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT.
    Cell Host Microbe; 2011 Jun 16; 9(6):451-62. PubMed ID: 21669394
    [Abstract] [Full Text] [Related]

  • 19. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL, Snyder HL, Krzych U.
    J Immunol; 1996 May 01; 156(9):3374-81. PubMed ID: 8617963
    [Abstract] [Full Text] [Related]

  • 20. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
    Kreutzfeld O, Müller K, Matuschewski K.
    Front Cell Infect Microbiol; 2017 May 01; 7():198. PubMed ID: 28620583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.